Skip to main content
Erschienen in: Clinical Oral Investigations 12/2021

20.09.2021 | Review

Efficacy of hyaluronic acid for recurrent aphthous stomatitis: a systematic review of clinical trials

verfasst von: Sadeq Ali Al-Maweri, Nader Alaizari, Rawan Hejji Alanazi, Sajna Ashraf, Rania Hejji Alanazi, Hesham Mohammed Al-Sharani, Esam Halboub

Erschienen in: Clinical Oral Investigations | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Recurrent aphthous stomatitis (RAS) is a very common oral mucosal disease, and its management is quite challenging with no definitive cure being available so far. Many studies have tried hyaluronic acid (HA) for alleviating signs and symptoms of RAS. The present systematic review sought to assess the available evidence regarding the efficacy of HA in management of RAS.

Methods

Two reviewers independently conducted extensive search in four online databases (PubMed, Scopus, Web of Science, and Google Scholar) and the gray literature, with no restriction to date or language of the publication. All clinical trials that assessed the efficacy of HA in reducing signs and symptoms of RAS were included. Risk of bias was assessed by two reviewers independently, using the Cochrane assessment tool. Due to substantial heterogeneity, no meta-analysis was feasible.

Results

Out of the 75 identified articles, nine clinical trials involving 538 RAS patients (259 in HA group) were included. The risk of bias was high in five studies, low in one study, and unclear in three studies. The comparative groups varied greatly across the included studies: triamcinolone (in three studies), chlorhexidine mouthwash, lidocaine, placebo, iodine glycerin, diclofenac, and laser therapy. Overall, the results revealed a good efficacy of HA in alleviating pain and shortening the healing time of RAS, without any reported side effects. Compared to triamcinolone, HA showed superior results in one study, and comparable results in two studies.

Conclusions

The available evidence suggests that HA is a promising treatment option for RAS. However, given the huge heterogeneity of the included studies and high risk of bias in some of these studies, the evidence is inconclusive. Further well-designed clinical trials with standardized methodologies and adequate sample sizes are warranted to discern the efficacy of HA for RAS.

Clinical relevance

Hyaluronic acid might be a viable alternative therapeutic option for patients with RAS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Tarakji B, Gazal G, Al-Maweri SA, Azzeghaiby SN, Alaizari N (2015) Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health 7:74–80PubMedPubMedCentral Tarakji B, Gazal G, Al-Maweri SA, Azzeghaiby SN, Alaizari N (2015) Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health 7:74–80PubMedPubMedCentral
4.
Zurück zum Zitat Al-Johani K (2019) Prevalence of recurrent aphthous stomatitis among dental students: a cross sectional study. J Contemp Dent Pract 20:893–895CrossRef Al-Johani K (2019) Prevalence of recurrent aphthous stomatitis among dental students: a cross sectional study. J Contemp Dent Pract 20:893–895CrossRef
5.
Zurück zum Zitat Al-Maweri SA, Halboub E, Al-Sharani H, Shamala A, Al-Kamel A, Al-Wesabi M, Albashari A, Al-Sharani A, Abdulrab S (2020) Association between serum zinc levels and recurrentaphthous stomatitis: a meta-analysis with trial sequentialanalysis. Clin Oral Investig 25(2):407–415 CrossRef Al-Maweri SA, Halboub E, Al-Sharani H, Shamala A, Al-Kamel A, Al-Wesabi M, Albashari A, Al-Sharani A, Abdulrab S (2020) Association between serum zinc levels and recurrentaphthous stomatitis: a meta-analysis with trial sequentialanalysis. Clin Oral Investig 25(2):407–415 CrossRef
9.
Zurück zum Zitat Shen C, Ye W, Gong L, Lv K, Gao B, Yao H (2021) Serum interleukin-6, interleukin-17A, and tumor necrosis factor-alpha in patients with recurrent aphthous stomatitis. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 50:418–423. https://doi.org/10.1111/jop.13158CrossRef Shen C, Ye W, Gong L, Lv K, Gao B, Yao H (2021) Serum interleukin-6, interleukin-17A, and tumor necrosis factor-alpha in patients with recurrent aphthous stomatitis. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 50:418–423. https://​doi.​org/​10.​1111/​jop.​13158CrossRef
11.
Zurück zum Zitat Ozyurt K, Celik A, Sayarlıoglu M, Colgecen E, Incı R, Karakas T, Kelles M, Cetin GY (2014) Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 43:691–695. https://doi.org/10.1111/jop.12182CrossRef Ozyurt K, Celik A, Sayarlıoglu M, Colgecen E, Incı R, Karakas T, Kelles M, Cetin GY (2014) Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 43:691–695. https://​doi.​org/​10.​1111/​jop.​12182CrossRef
13.
Zurück zum Zitat Halboub E, Al-Maweri SA, Parveen S, Al-Wesabi M, Al-Sharani HM, Al-Sharani A, Al-Kamel A, Albashari A, Shamala A (2021) Zinc supplementation for prevention and management of recurrent aphthous stomatitis: a systematic review. J Trace Elem Med Biol Organ Soc Miner Trace Elem (GMS) 68:126811. https://doi.org/10.1016/j.jtemb.2021.126811CrossRef Halboub E, Al-Maweri SA, Parveen S, Al-Wesabi M, Al-Sharani HM, Al-Sharani A, Al-Kamel A, Albashari A, Shamala A (2021) Zinc supplementation for prevention and management of recurrent aphthous stomatitis: a systematic review. J Trace Elem Med Biol Organ Soc Miner Trace Elem (GMS) 68:126811. https://​doi.​org/​10.​1016/​j.​jtemb.​2021.​126811CrossRef
15.
Zurück zum Zitat El-Haddad SA, Asiri FY, Al-Qahtani HH, Al-Ghmlas AS (2014) Efficacy of honey in comparison to topical corticosteroid for treatment of recurrent minor aphthous ulceration: a randomized, blind, controlled, parallel, double-center clinical trial. Quintessence Int (Berlin, Germany: 1985) 45:691–701. https://doi.org/10.3290/j.qi.a32241CrossRef El-Haddad SA, Asiri FY, Al-Qahtani HH, Al-Ghmlas AS (2014) Efficacy of honey in comparison to topical corticosteroid for treatment of recurrent minor aphthous ulceration: a randomized, blind, controlled, parallel, double-center clinical trial. Quintessence Int (Berlin, Germany: 1985) 45:691–701. https://​doi.​org/​10.​3290/​j.​qi.​a32241CrossRef
21.
Zurück zum Zitat Zeng Q, Shi X, Yang J, Yang M, Zhao W, Zhao X, Shi J, Zhou H (2020) The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: a randomized controlled clinical trial. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 49:357–364. https://doi.org/10.1111/jop.12960CrossRef Zeng Q, Shi X, Yang J, Yang M, Zhao W, Zhao X, Shi J, Zhou H (2020) The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: a randomized controlled clinical trial. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 49:357–364. https://​doi.​org/​10.​1111/​jop.​12960CrossRef
29.
Zurück zum Zitat Casale M, Moffa A, Vella P, Rinaldi V, Lopez MA, Grimaldi V, Salvinelli F (2017) Systematic review: the efficacy of topical hyaluronic acid on oral ulcers. J Biol Regul Homeost Agents 31:63–69PubMed Casale M, Moffa A, Vella P, Rinaldi V, Lopez MA, Grimaldi V, Salvinelli F (2017) Systematic review: the efficacy of topical hyaluronic acid on oral ulcers. J Biol Regul Homeost Agents 31:63–69PubMed
32.
Zurück zum Zitat Jacobus Berlitz S, De Villa D, MaschmannInacio LA, Davies S, Zatta KC, Guterres SS, Külkamp-Guerreiro IC (2019) Azelaic acid-loaded nanoemulsion with hyaluronic acid–a new strategy to treat hyperpigmentary skin disorders. Drug Dev Ind Pharm 45:642–650CrossRef Jacobus Berlitz S, De Villa D, MaschmannInacio LA, Davies S, Zatta KC, Guterres SS, Külkamp-Guerreiro IC (2019) Azelaic acid-loaded nanoemulsion with hyaluronic acid–a new strategy to treat hyperpigmentary skin disorders. Drug Dev Ind Pharm 45:642–650CrossRef
33.
Zurück zum Zitat Fariba I, Taghi G, Mazdak E, Maryam T, Hossein S, Shahla E, Zabiholah S (2005) The efficacy of 3% diclofenac in 2.5% hyaluronan gel base for treatment of recurrent aphthous stomatitis (RAS): A double blind study. Egypt Dermatol Online J 1:4 Fariba I, Taghi G, Mazdak E, Maryam T, Hossein S, Shahla E, Zabiholah S (2005) The efficacy of 3% diclofenac in 2.5% hyaluronan gel base for treatment of recurrent aphthous stomatitis (RAS): A double blind study. Egypt Dermatol Online J 1:4
34.
Zurück zum Zitat Hamed GY (2015) The efficacy of hyaluronic acid spray in treatment of recurrent aphthus ulcer. Int J Enhanc Res Sci Technol Eng 4:82–86CrossRef Hamed GY (2015) The efficacy of hyaluronic acid spray in treatment of recurrent aphthus ulcer. Int J Enhanc Res Sci Technol Eng 4:82–86CrossRef
35.
Zurück zum Zitat Koray M, Ofluoglu D, Senemtasi A, İşsever H, Yaltirik M (2016) The efficacy of hyaluronic acid gel in pain control of recurrent Aphthous stomatitis. Int J Dent Oral Sci 3:273–275 Koray M, Ofluoglu D, Senemtasi A, İşsever H, Yaltirik M (2016) The efficacy of hyaluronic acid gel in pain control of recurrent Aphthous stomatitis. Int J Dent Oral Sci 3:273–275
36.
Zurück zum Zitat Mustafa BN, Alzubaidee AF (2020) Comparative evaluation of the efficacy of topical hyaluronic acid (0.2%) and topical triamcinolone acetonide (0.1%) in the treatment of recurrent aphthous stomatitis. Diyala J Med 19:107–117CrossRef Mustafa BN, Alzubaidee AF (2020) Comparative evaluation of the efficacy of topical hyaluronic acid (0.2%) and topical triamcinolone acetonide (0.1%) in the treatment of recurrent aphthous stomatitis. Diyala J Med 19:107–117CrossRef
37.
Zurück zum Zitat Shalaby HKM (2019) Effect of diode laser combined with hyaluronic acid gel in treatment of recurrent aphthous stomatitis in children: randomized clinical trial. Egypt Dent J 65:3555–3566CrossRef Shalaby HKM (2019) Effect of diode laser combined with hyaluronic acid gel in treatment of recurrent aphthous stomatitis in children: randomized clinical trial. Egypt Dent J 65:3555–3566CrossRef
38.
Zurück zum Zitat Zakaria M, Abdelwhab A, Hassan S (2020) Effectiveness of topical hyaluronic acid versus chlorhexidine mouthwashes in the treatment of recurrent aphthous stomatitis: a randomized clinical trial. Egypt Dent J 66:1537–1543CrossRef Zakaria M, Abdelwhab A, Hassan S (2020) Effectiveness of topical hyaluronic acid versus chlorhexidine mouthwashes in the treatment of recurrent aphthous stomatitis: a randomized clinical trial. Egypt Dent J 66:1537–1543CrossRef
40.
43.
Zurück zum Zitat Tan R, D-m HU, K-e HU (2012) Study on the effect of hyaluronic acid on the treatment of recurrent oral ulceration. Chin J Aesthet Med 2012:14 Tan R, D-m HU, K-e HU (2012) Study on the effect of hyaluronic acid on the treatment of recurrent oral ulceration. Chin J Aesthet Med 2012:14
44.
Zurück zum Zitat Lopez MA, Manzulli N, D’Angelo A, Candotto V, Casale M, Lauritano D (2017) The use of hyaluronic acid as an adjuvant in the management of mucositis. J Biol Regul Homeost Agents 31:115–118PubMed Lopez MA, Manzulli N, D’Angelo A, Candotto V, Casale M, Lauritano D (2017) The use of hyaluronic acid as an adjuvant in the management of mucositis. J Biol Regul Homeost Agents 31:115–118PubMed
Metadaten
Titel
Efficacy of hyaluronic acid for recurrent aphthous stomatitis: a systematic review of clinical trials
verfasst von
Sadeq Ali Al-Maweri
Nader Alaizari
Rawan Hejji Alanazi
Sajna Ashraf
Rania Hejji Alanazi
Hesham Mohammed Al-Sharani
Esam Halboub
Publikationsdatum
20.09.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 12/2021
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-021-04180-4

Weitere Artikel der Ausgabe 12/2021

Clinical Oral Investigations 12/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.